Patent US4355029A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4355029A Expired / Lapsed US ⏱️ 0.0 years remaining

Combination therapy for rheumatoid arthritis

Assignee: Eli Lilly and Co
•
Filing: 1981-06-01
•
Granted: 1982-10-19
•
Expires: 2001-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A therapeutic method for treating rheumatoid arthritis in which benoxaprofen plus aspirin are administered once a day and aspirin alone three times a day, all dosages being given at six hour intervals.

Inventors

  • 👤 Anthony S. Ridolfo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 10:53
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/60

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 69 words
A treatment method for rheumtoid arthritis which comprises administering to a patient suffering from rheumatoid arthritis a combination of from 200 to 820 mg. of benoxaprofen and 325 to 1170 mg. of aspirin once a day, from 325 to 1170 mg. of aspirin alone three times a day, all dosages to be administered at approximately six hour intervals; and then repeating the above daily dosage schedule on succeeding days.
Claim 2
Dependent Claim 69 words
A treatment method for rheumtoid arthritis which comprises administering to a patient suffering from rheumatoid arthritis a combination of from 200 to 820 mg. of benoxaprofen and 325 to 1170 mg. of aspirin once a day, from 325 to 1170 mg. of aspirin alone three times a day, all dosages to be administered at approximately six hour intervals; and then repeating the above daily dosage schedule on succeeding days.
Claim 3
Dependent Claim 35 words
A process according to claim 1 in which a combination of 600 mg. of benoxaprofen and 975 mg. of aspirin are administered once a day and 975 mg. of aspirin only three times a day.

References Cited (Backward Citations)

USRE29608E Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-10-18 1986-04-19 1986-10-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-10-18 1990-04-19 1990-10-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-10-18 1994-04-19 1994-10-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag